GO:0034478 phosphatidylglycerol catabolic process: Lipid Remodeling Pathway, Genes, Functions and Research Methods
Research-grade guide for scientists and biopharma professionals
Key Takeaways
• GO:0034478 phosphatidylglycerol catabolic process describes the biochemical breakdown of phosphatidylglycerol (PG), a major anionic glycerophospholipid in bacterial, mitochondrial and photosynthetic membranes.
• PG catabolism is essential for membrane lipid remodeling, generation of precursors for cardiolipin and bis(monoacylglycero)phosphate (BMP), and maintenance of membrane charge and curvature.
• Key enzymes include phospholipases (e.g., PlcP, PldA), phosphatases (e.g., PgpB, Gep4) and lysophospholipases that deacylate PG or remove its phosphatidyl group.
• Dysregulated PG catabolism is linked to mitochondrial dysfunction, surfactant abnormalities in lung disease, and bacterial membrane remodeling during infection.
• CRISPR knockout, point-mutation, knock-in and overexpression models enable causal dissection of PG catabolic enzymes in human cells and model organisms.
• Studying GO:0034478 requires lipidomics, isotope tracing, enzyme assays and imaging, often combined with CRISPR library screening to identify novel regulators.
Description
Phosphatidylglycerol (PG) is a ubiquitous anionic glycerophospholipid found in bacterial membranes, mitochondrial inner membranes and photosynthetic thylakoids. The Gene Ontology term GO:0034478, phosphatidylglycerol catabolic process, defines the set of biochemical reactions that result in the breakdown of PG, including its deacylation, dephosphorylation and conversion into other lipids. This process is not merely degradative; it supplies precursors for cardiolipin and bis(monoacylglycero)phosphate (BMP), regulates membrane charge and curvature, and participates in host-pathogen interactions. Researchers study PG catabolism to understand membrane homeostasis, mitochondrial function, surfactant metabolism and bacterial resistance mechanisms. The availability of CRISPR-based tools now allows precise perturbation of PG catabolic genes in diverse cell models, accelerating functional discovery.
phosphatidylglycerol catabolic process At A Glance
| GO ID | GO:0034478 |
|---|---|
| GO term | phosphatidylglycerol catabolic process |
| Ontology | biological_process |
| Synonym | phosphatidylglycerol breakdown; phosphatidylglycerol catabolism; phosphatidylglycerol degradation |
| Major function | Breakdown of phosphatidylglycerol to lysophosphatidylglycerol, glycerol-3-phosphate and fatty acids; generation of lipid precursors |
| Key enzymes | Phospholipases (PlcP, PldA), phosphatases (PgpB, Gep4), lysophospholipases |
| Cellular locations | Bacterial inner membrane, mitochondrial inner membrane, thylakoid membrane, lysosome |
| Related pathways | Cardiolipin biosynthesis, BMP synthesis, surfactant phospholipid metabolism, membrane remodeling |
What Is GO:0034478?
GO:0034478 phosphatidylglycerol catabolic process encompasses the chemical reactions and pathways that result in the breakdown of phosphatidylglycerols, a class of glycerophospholipids in which the phosphatidyl group is esterified to the hydroxyl group of glycerol. This includes enzymatic removal of acyl chains (deacylation), cleavage of the phosphatidyl group (phospholipase activity), and further conversion of the resulting lysophosphatidylglycerol or glycerol-3-phosphate derivatives. The term is a biological process and is synonymous with phosphatidylglycerol breakdown, catabolism and degradation.
Why Is phosphatidylglycerol catabolic process Important in Cell Biology?
Phosphatidylglycerol catabolism is critical for maintaining membrane lipid homeostasis and for generating lipid second messengers and precursors. In bacteria, PG breakdown contributes to membrane remodeling during stress and infection, and some bacterial effectors target anionic phospholipids including PG to disrupt host membranes. In mitochondria, PG is a precursor of cardiolipin, and its catabolism influences respiratory chain function and mitochondrial dynamics. In lung surfactant, PG is a major phospholipid, and its catabolism affects surfactant pool size and function. Thus, GO:0034478 is relevant to infectious disease, mitochondrial disorders, respiratory disease and cancer metabolism.
• Maintains membrane lipid asymmetry and charge by removing excess anionic PG.
• Provides precursors for cardiolipin and bis(monoacylglycero)phosphate (BMP) synthesis.
• Supports bacterial membrane remodeling and resistance to host antimicrobial peptides.
• Regulates lung surfactant phospholipid composition and turnover.
• Impacts mitochondrial inner membrane integrity and energy metabolism.
• Influences lysosomal lipid degradation and trafficking through BMP production.
• Serves as a target for bacterial T6SS effectors that hydrolyze anionic phospholipids.
• Chemokines can kill bacteria by binding anionic phospholipids, linking PG catabolism to host defense.
• Dysregulation is associated with surfactant abnormalities and respiratory distress.
• Offers a pathway for therapeutic intervention in infections and mitochondrial diseases.
What Happens During phosphatidylglycerol catabolic process?
Substrate recognition and phospholipase-mediated deacylation
In simple terms: Enzymes recognize PG in the membrane and start cutting off its fatty acid tails.
The first step in PG catabolism often involves phospholipases that hydrolyze the acyl ester bonds of PG. Bacterial phospholipase A (PldA) and related enzymes can remove one acyl chain to produce lysophosphatidylglycerol (LPG). In Salmonella, T6SS effectors with lipid-targeting activities can degrade anionic phospholipids including PG, demonstrating a role in interbacterial competition. These phospholipases are membrane-associated and require calcium or other cofactors for activity.
Dephosphorylation and glycerol backbone release
In simple terms: After the fatty acids are removed, the phosphate group is clipped off to release glycerol and phosphate.
Phosphatases such as PgpB in bacteria and Gep4 in yeast remove the phosphatidyl group from PG or LPG, yielding glycerol-3-phosphate and diacylglycerol or monoacylglycerol. This step is important for recycling phosphate and for generating signaling lipids. In photosynthetic organisms, PG catabolism is linked to the turnover of thylakoid lipids and the production of free fatty acids.
Conversion to cardiolipin and bis(monoacylglycero)phosphate
In simple terms: Some breakdown products are not waste but are used to build other important lipids.
PG is a direct precursor of cardiolipin, a mitochondrial signature lipid. The enzyme cardiolipin synthase condenses PG with CDP-diacylglycerol to form cardiolipin. In lysosomes, PG catabolism contributes to the synthesis of bis(monoacylglycero)phosphate (BMP), a lipid required for lysosomal function. Functionally overlapping intra- and extralysosomal pathways promote BMP synthesis in mammalian cells.
Membrane remodeling and lipid homeostasis
In simple terms: Breaking down PG helps the cell adjust its membrane composition in response to stress.
PG catabolism is part of a broader membrane remodeling network. In bacteria, changes in PG levels affect membrane fluidity and susceptibility to antimicrobial peptides. In mitochondria, PG catabolism influences cristae morphology and respiratory chain supercomplex assembly. In lung surfactant, PG catabolism regulates the pool of surfactant phospholipids, which is critical for alveolar stability.
Key Genes Involved in GO:0034478 phosphatidylglycerol catabolic process
The following genes and proteins are experimentally implicated in phosphatidylglycerol catabolic process (GO:0034478) or in related PG metabolic pathways, based on published literature.
| Gene | Major Role | Research Relevance |
|---|---|---|
| PLD1 | Phospholipase D, hydrolyzes phosphatidylcholine; can transphosphatidylate to PG | Studied in membrane lipid remodeling and cancer |
| PLA2G | Phospholipase A2, removes acyl chain from PG | Involved in surfactant phospholipid catabolism |
| PgpB | Phosphatidylglycerophosphate phosphatase, dephosphorylates PG precursors | Bacterial PG synthesis and catabolism |
| Gep4 | Phosphatidylglycerophosphate phosphatase in yeast | Mitochondrial PG metabolism |
| CLS1 | Cardiolipin synthase, uses PG as substrate | Mitochondrial cardiolipin biosynthesis |
| PldA | Bacterial phospholipase A, degrades PG | Outer membrane remodeling in bacteria |
| PlcP | Bacterial phospholipase C, hydrolyzes PG | Membrane lipid catabolism in bacteria |
| LPGAT1 | Lysophosphatidylglycerol acyltransferase, reacylates LPG | Regulates PG catabolism intermediates |
| ABHD12 | Lysophospholipase, degrades lysophosphatidylglycerol | Neurodegenerative disease and lipid metabolism |
| PLAAT3 | Phospholipase A/acyltransferase, hydrolyzes PG | Membrane lipid remodeling |
| LPCAT | Lysophosphatidylcholine acyltransferase, can act on LPG | Surfactant metabolism |
| PPT1 | Palmitoyl-protein thioesterase, involved in lysosomal lipid catabolism | BMP synthesis and lysosomal function |
| NPC1 | Niemann-Pick C1, cholesterol and lipid trafficking | Lysosomal lipid catabolism |
| T6SS effectors | Lipid-targeting effectors that degrade PG | Bacterial competition and pathogenesis |
| CXCL10 | Chemokine that binds anionic phospholipids including PG | Host defense against bacteria |
| SP-B | Surfactant protein B, interacts with PG | Surfactant homeostasis |
| SP-C | Surfactant protein C, interacts with PG | Surfactant homeostasis |
How Is phosphatidylglycerol catabolic process Regulated?
Phosphatidylglycerol catabolic process is regulated at multiple levels. In bacteria, phospholipase expression is controlled by stress-responsive sigma factors and two-component systems that sense membrane stress. In mitochondria, PG catabolism is coupled to cardiolipin synthesis and mitochondrial biogenesis, and is influenced by the availability of CDP-diacylglycerol. In lung surfactant, PG catabolism is regulated by surfactant protein interactions and by hormonal signals that control surfactant secretion and reuptake. In lysosomes, BMP synthesis from PG is regulated by intra- and extralysosomal pathways that respond to lipid loading. Additionally, host chemokines such as CXCL10 can bind anionic phospholipids and modulate bacterial membrane integrity, indirectly affecting PG catabolism.
phosphatidylglycerol catabolic process and Human Disease
| Gene | Disease / Biology | Potential Experimental Model |
|---|---|---|
| CLS1 | Mitochondrial myopathy, cardiolipin deficiency | CRISPR knockout in HEK293T or HeLa cells; mitochondrial respiration assays |
| ABHD12 | Neurodegeneration, lysosomal lipid storage | Knockout in SH-SY5Y or primary neurons; lipidomics |
| SP-B | Respiratory distress syndrome | Knockout in A549 or primary alveolar type II cells; surfactant analysis |
| PldA | Bacterial membrane remodeling, infection | Knockout in Salmonella or E. coli; antimicrobial peptide sensitivity |
| CXCL10 | Host defense against bacteria | Overexpression in epithelial cells; bacterial killing assays |
Mitochondrial dysfunction and cardiolipin-related disorders
PG is the precursor of cardiolipin, a phospholipid essential for mitochondrial function. Defects in PG catabolism can alter cardiolipin levels, leading to mitochondrial dysfunction, reduced oxidative phosphorylation and increased reactive oxygen species. Mutations in genes involved in PG metabolism, such as CLS1, are associated with Barth syndrome-like phenotypes and other mitochondrial myopathies.
Respiratory distress syndrome and surfactant abnormalities
Phosphatidylglycerol is a major component of lung surfactant, and its catabolism affects surfactant pool size and composition. Abnormal PG catabolism has been linked to respiratory distress syndrome in neonates and to surfactant dysfunction in adults. Surfactant proteins SP-B and SP-C interact with PG and regulate its turnover.
Bacterial infections and antimicrobial resistance
Bacterial pathogens remodel their membranes by modifying PG catabolism to resist host antimicrobial peptides and chemokines. Salmonella T6SS effectors degrade PG to compete with other bacteria. Chemokines such as CXCL10 kill bacteria by binding anionic phospholipids, and bacterial PG catabolism may counteract this host defense.
Lysosomal storage and neurodegenerative disease
Bis(monoacylglycero)phosphate (BMP), synthesized in part from PG catabolism, is critical for lysosomal lipid degradation. Defects in BMP synthesis or PG catabolism contribute to lysosomal storage disorders and neurodegeneration, including ABHD12-related disease.
From phosphatidylglycerol catabolic process-Related Genes to Experimental Models
| Research Question | Suitable Model |
|---|---|
| Does loss of a candidate PG catabolic enzyme alter PG levels? | CRISPR knockout in HEK293T or HeLa cells followed by lipidomics |
| Does a point mutation in the active site abolish enzyme activity? | CRISPR point mutation (e.g., catalytic residue) in the endogenous locus |
| Can a tagged version of the enzyme be used for localization studies? | Knock-in of GFP or HA tag at the endogenous locus |
| Does overexpression of the enzyme reduce PG and increase LPG? | Overexpression via lentiviral transduction in mammalian cells |
| Which genes regulate PG catabolism in bacteria? | CRISPR interference (CRISPRi) library screening in E. coli or Salmonella |
| Does PG catabolism affect mitochondrial function? | Knockout in HeLa cells followed by Seahorse respiration assays |
How to Study the phosphatidylglycerol catabolic process Process
| Method | What It Measures | Typical Application |
|---|---|---|
| Lipidomics (LC-MS/MS) | Relative and absolute levels of PG, LPG, and other lipids | Quantifying PG catabolism in knockout cells |
| Isotope tracing | Flux through PG catabolic pathways | Determining precursor-product relationships |
| Phospholipase activity assay | Enzymatic hydrolysis of PG | Validating candidate enzymes |
| CRISPR knockout screening | Genes required for PG catabolism | Identifying novel regulators |
| Western blot | Protein expression levels | Confirming knockout or overexpression |
| Fluorescence microscopy | Subcellular localization of enzymes | Visualizing membrane remodeling |
| Seahorse respiration assay | Mitochondrial function | Linking PG catabolism to energy metabolism |
| Bacterial killing assay | Host defense against bacteria | Testing chemokine-mediated killing |
Lipidomics and mass spectrometry
Mass spectrometry-based lipidomics is the gold standard for measuring PG and its catabolic products, such as LPG and glycerol-3-phosphate. Researchers use targeted or untargeted lipidomics to quantify changes in PG species after genetic perturbation. Isotope tracing with deuterated or 13C-labeled precursors can reveal flux through catabolic pathways.
Enzyme activity assays
In vitro enzyme assays using fluorescent or radiolabeled PG substrates measure phospholipase and phosphatase activities. These assays are used to validate the catalytic function of candidate enzymes and to determine kinetic parameters. They can be performed with recombinant proteins or membrane fractions.
CRISPR screening and functional genomics
Genome-wide CRISPR knockout or interference screens can identify genes that regulate PG catabolism. For example, screens in bacteria have uncovered T6SS effectors that target PG. In mammalian cells, CRISPR screens coupled with lipidomics can reveal novel regulators of PG breakdown.
Imaging and subcellular localization
Fluorescence microscopy with tagged enzymes or lipid probes can visualize the subcellular sites of PG catabolism. Knock-in of fluorescent tags allows tracking of endogenous enzymes. Live-cell imaging can monitor membrane remodeling in real time.
How CRISPR Can Be Used to Study GO:0034478 phosphatidylglycerol catabolic process
Knockout
CRISPR knockout of genes involved in PG catabolism, such as PLD1, ABHD12 or CLS1, allows researchers to assess their contribution to lipid homeostasis. Knockout cell lines can be analyzed by lipidomics to measure PG accumulation or depletion. In bacteria, knockout of PldA or PlcP reveals their role in membrane remodeling and resistance to antimicrobial peptides.
Point Mutation
CRISPR point mutation can introduce catalytic dead mutations in PG catabolic enzymes to separate enzymatic activity from scaffolding functions. For example, mutating the active-site serine of a phospholipase can abolish hydrolysis while preserving protein interactions. These models are valuable for dissecting signaling versus metabolic roles.
Knock-in
Knock-in of epitope tags (e.g., GFP, HA) or fluorescent proteins at the endogenous locus enables visualization and immunoprecipitation of PG catabolic enzymes under native regulation. Knock-in of disease-associated mutations can model human disorders linked to PG metabolism.
Overexpression
Overexpression of PG catabolic enzymes using lentiviral or piggyBac systems can drive excessive PG breakdown, leading to altered membrane composition and cellular phenotypes. This approach is useful for gain-of-function studies and for testing therapeutic hypotheses.
How EDITGENE Supports phosphatidylglycerol catabolic process Research
Researchers studying phosphatidylglycerol catabolic process-related genes often need to determine whether a candidate gene is causally involved in lipid remodeling, mitochondrial function or bacterial pathogenesis. CRISPR-based models provide the precision required to link genotype to lipid phenotype.
Contact EDITGENE today to design your custom CRISPR model for phosphatidylglycerol catabolic process research.
Frequently Asked Questions About phosphatidylglycerol catabolic process
What is GO:0034478 phosphatidylglycerol catabolic process?
GO:0034478 is a Gene Ontology biological process term describing the chemical reactions and pathways that break down phosphatidylglycerol, a major anionic glycerophospholipid, into lysophosphatidylglycerol, glycerol-3-phosphate and fatty acids.
What genes are involved in phosphatidylglycerol catabolic process?
Key genes include phospholipases such as PLD1, PldA and PlcP, phosphatases like PgpB and Gep4, and lysophospholipases such as ABHD12.
Why is phosphatidylglycerol catabolism important for bacteria?
Bacteria remodel their membranes by degrading PG to resist antimicrobial peptides and to compete with other bacteria via T6SS effectors.
How is phosphatidylglycerol catabolism linked to mitochondria?
PG is a precursor of cardiolipin, a mitochondrial lipid essential for energy metabolism; its catabolism affects mitochondrial function.
What diseases are associated with defects in phosphatidylglycerol catabolism?
Defects are linked to mitochondrial myopathies, respiratory distress syndrome, lysosomal storage disorders and increased susceptibility to infections.
What methods are used to study phosphatidylglycerol catabolic process?
Lipidomics, isotope tracing, enzyme activity assays, CRISPR screening and fluorescence microscopy are commonly used.
Can CRISPR be used to study phosphatidylglycerol catabolism?
Yes, CRISPR knockout, point mutation, knock-in and overexpression models enable precise perturbation of PG catabolic genes in various cell types.
What is the role of bis(monoacylglycero)phosphate in PG catabolism?
BMP is synthesized in part from PG catabolism and is critical for lysosomal lipid degradation; defects lead to lysosomal storage.
How do chemokines affect phosphatidylglycerol in bacteria?
Chemokines such as CXCL10 bind anionic phospholipids including PG, disrupting bacterial membranes and killing bacteria without triggering resistance.
What are the research tools for GO:0034478?
EDITGENE provides CRISPR knockout, point mutation, knock-in, overexpression cell models and CRISPR library screening for PG catabolism research.
Conclusion
GO:0034478 phosphatidylglycerol catabolic process is a fundamental biological process that maintains membrane lipid homeostasis and supplies precursors for cardiolipin and BMP. Its dysregulation is implicated in mitochondrial disease, respiratory distress, lysosomal storage disorders and bacterial pathogenesis. CRISPR-based models are powerful tools to dissect the causal roles of PG catabolic genes, and EDITGENE offers comprehensive services to accelerate this research.
References
- 1. Bulfon D et al.. 2024. Functionally overlapping intra- and extralysosomal pathways promote bis(monoacylglycero)phosphate synthesis in mammalian cells.. Nat Commun 15(1):9937 PMID: 39548099
- 2. Guan Z et al.. 2021. Lipid diversity in clostridia.. Biochim Biophys Acta Mol Cell Biol Lipids 1866(9):158966 PMID: 33974975
- 3. Agassandian M et al.. 2013. Surfactant phospholipid metabolism.. Biochim Biophys Acta 1831(3):612-25 PMID: 23026158
- 4. Kobayashi K et al.. 2024. Biosynthesis of phosphatidylglycerol in photosynthetic organisms.. Prog Lipid Res 93:101266 PMID: 38040200
- 5. Nicastro GG et al.. 2026. Systematic identification of Salmonella T6SS effectors uncovers diverse new families and lipid-targeting activities.. PLoS Biol 24(3):e3003680 PMID: 41843574
- 6. Mayr JA. 2015. Lipid metabolism in mitochondrial membranes.. J Inherit Metab Dis 38(1):137-44 PMID: 25082432
- 7. Batenburg JJ. 1992. Surfactant phospholipids: synthesis and storage.. Am J Physiol 262(4 Pt 1):L367-85 PMID: 1566854
- 8. Pontejo SM et al.. 2025. Chemokines kill bacteria without triggering antimicrobial resistance by binding anionic phospholipids.. Sci Adv 11(23):eads2675 PMID: 40479071
